Healthcare & Life Sciences

Tioga Cardiovascular

aliveseries-c-plus
series-c-plus
Stage
1
Investors

About

Tioga Cardiovascular develops transseptal, low-profile transcatheter valve replacement technologies for treating mitral and tricuspid heart valve diseases.

Explore Tioga Cardiovascular's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.